What is Dianthus Therapeutics's PP&E (net)?

Dianthus Therapeutics (DNTH) reported PP&E (net) of $274K in Q1 2026.

How has Dianthus Therapeutics's PP&E (net) changed year-over-year?

Dianthus Therapeutics's PP&E (net) increased by 43.5% year-over-year, from $191K to $274K.

What is the long-term trend for Dianthus Therapeutics's PP&E (net)?

Over 5 years (2020 to 2025), Dianthus Therapeutics's PP&E (net) has grown at a -48.7% compound annual growth rate (CAGR), from $8.31M to $296K.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Dianthus Therapeutics DNTH PP&E (Net)

PP&E (Net) at other companies

Johnson & JohnsonJNJ

$23.27B+11.5%

AmgenAMGN

$8.22B+23.0%

Kymera TherapeuticsKYMR

$41.62M-15.4%

Protagonist TherapeuticsPTGX

$3.78M+7.0%

Immunovant, Inc.IMVT

$443K-47.5%

BiogenBIIB

$3.02B-3.7%

Other financials

Income statement

See full

Revenue$396.0K-81.8%

Operating income-$46.5M-40.3%

Net income-$40.8M-38.4%

EPS (diluted)-$0.85-3.7%

Balance sheet

See full

Cash & equivalents$627.7M+6,105%

Total debt$1.4M-2.3%

Total equity$1.2B+266%

Total assets$1.2B+258%

Cash flow

See full

Operating cash flow-$28.9M-4.4%

CapEx$10.0K-58.3%

Free cash flow-$28.9M-4.4%

Valuation

See full

Market cap$4.51B+662%

Profitability

See full

Operating margin-4,558.4%-9,354pp

Net margin-4,104.8%-7,304pp

FCF margin-3,561.6%-6,956pp

Returns & leverage

See full

Return on equity-28.6%+3.2pp

Debt / equity0×0.0×

Current ratio29.3×+13.3×

Where this comes from

Reported directly by Dianthus Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Dianthus Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dianthus Therapeutics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dianthus Therapeutics's PP&E (net)?: Dianthus Therapeutics (DNTH) reported PP&E (net) of $274K in Q1 2026.
How has Dianthus Therapeutics's PP&E (net) changed year-over-year?: Dianthus Therapeutics's PP&E (net) increased by 43.5% year-over-year, from $191K to $274K.
What is the long-term trend for Dianthus Therapeutics's PP&E (net)?: Over 5 years (2020 to 2025), Dianthus Therapeutics's PP&E (net) has grown at a -48.7% compound annual growth rate (CAGR), from $8.31M to $296K.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.